SCHEDULE: T. Rowe Price Reports Stake in Hanover Insurance

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of 5.2% of Hanover Insurance Group Inc.'s common stock as of June 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has filed a Schedule 13G, indicating their beneficial ownership of Hanover Insurance Group Inc. common stock.
• As of June 30, 2026, T. Rowe Price beneficially owned 1,831,584 shares, representing 5.2% of the class.
• The filing confirms sole voting power over 1,819,788 shares and sole dispositive power over 1,831,584 shares.
• This filing is made under Rule 13d-1(b) and certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership percentage without significant new strategic or financial information.

Positives

• T. Rowe Price Associates, Inc. maintains a significant stake, indicating continued investment interest in Hanover Insurance Group Inc.

Negatives

• No new financial performance data or strategic initiatives are disclosed in this filing.

Risks

• The filing does not explicitly mention any new risks. However, any investment carries inherent market risks.
• Potential for future changes in beneficial ownership could impact stock price volatility.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding future performance.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors like T. Rowe Price when their beneficial ownership crosses a certain threshold. This filing indicates T. Rowe Price's ongoing role as a significant shareholder in the insurance sector.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be viewed positively for stability, but also implies potential for future trading activity that could influence share price.
• Management: The filing reinforces that T. Rowe Price is not seeking to influence control, which may be reassuring to current management.

Next Steps

• T. Rowe Price Associates, Inc. will continue to hold its shares in Hanover Insurance Group Inc. in the ordinary course of business.
• Future filings will be made if there are further changes in beneficial ownership.

Key Dates

Keywords

T. Rowe Price, Hanover Insurance Group, Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, Institutional Investor